Dynamic List Information
Dynamic List Data
Study Title
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
Sponsor Name
UT MD Anderson Cancer Center
NCT Number
NCT05092373
IDE Number
G210326
CMS Approval Date
2026-06-03
Clinical Trial Link
Category
A